Skip to main content
main-content

19.05.2017 | Review Article | Ausgabe 7/2017 Open Access

Graefe's Archive for Clinical and Experimental Ophthalmology 7/2017

Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti–vascular endothelial growth factor therapy of macular diseases

Zeitschrift:
Graefe's Archive for Clinical and Experimental Ophthalmology > Ausgabe 7/2017
Autoren:
Paolo Lanzetta, Anat Loewenstein, The Vision Academy Steering Committee
Wichtige Hinweise
Paolo Lanzetta and Anat Loewenstein are also members of the Vision Academy Steering Committee (all members are listed in the Appendix)

Abstract

Background

Intravitreal anti–vascular endothelial growth factor (VEGF) therapy is now considered the gold standard for the treatment of various retinal disorders. As therapy has evolved, so too have the treatment regimens employed by physicians in clinical practice; however, visual outcomes observed in the real world have typically not reflected those reported in clinical trials. Possible reasons for this include a lack of consensus on treatment regimens and a lack of clarity about what the aims of treatment should be.

Methods

The Vision Academy Steering Committee met to discuss the principles of an ideal treatment regimen, using evidence from the literature to substantiate each point. Literature searches were performed using the MEDLINE/PubMed database (cut-off date: March 2016) and restricted to English-language publications. Studies with fewer than ten patients were excluded from this review.

Results

The Steering Committee identified the following four key principles for the ideal treatment regimen for anti-VEGF management of retinal diseases:
1.
Maximize and maintain visual acuity (VA) benefits for all patients
 
2.
Decide when to treat next, rather than whether to treat now
 
3.
Titrate the treatment intervals to match patients’ needs
 
4.
Treat at each monitoring visit.
 

Conclusions

It is proposed that the adoption of a proactive and more personalized approach in the clinic such as a treat-and-extend regimen will lead to benefits for both the patient and the physician, through a reduction in the associated treatment burden and better utilization of clinic resources. Implementation of the four principles should also lead to better VA outcomes for each patient, with a minimized risk of vision loss.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Premium-Inhalten der Fachzeitschriften, inklusive eines Print-Abos.

Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 7/2017

Graefe's Archive for Clinical and Experimental Ophthalmology 7/2017Zur Ausgabe

Letter to the Editor (by invitation)

A recent finding in Fuchs uveitis: choroidal thinning

Neu im Fachgebiet Augenheilkunde

15.06.2018 | Video plus | Ausgabe 7/2018

Diakaustische Kammerwinkeluntersuchung

Videobeitrag

01.06.2018 | themenschwerpunkt | Ausgabe 3/2018

Das Kind in der Kunst

22.05.2018 | Das Frühgeborene | Leitthema | Ausgabe 6/2018

Frühgeborenenretinopathie in welchem Stadium wie behandeln?

Aktueller Wissensstand und Ausblick